A biological preparation made from killed or weakened microorganisms is known as vaccine.
A biological preparation made from killed or weakened microorganisms is known as vaccine. It consists of an agent that resembles with a disease-causing microorganism. The H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease in human beings commonly referred to as swine flu. The H1N1 virus mainly affects the respiratory system, including the nose, lungs, and throat of the infected person. The virus has caused a worldwide pandemic in the recent years.
Read Report Overview - https://www.transparencymarketresearch.com/h1n1-vaccines-market.html
The H1N1 virus can be classified on the basis of antigenicity of its surface glycoproteins hemagglutinin and neuraminidase. Hemagglutinin helps the virus bind to host cell receptors. This simplifies viral entry into the host cell. The neuraminidase protein enzymatically splits terminal sialic acid residues from mucins, thereby letting the virus reach underlying cells in the respiratory tract. H1N1 vaccines are administered for active immunization against the H1N1 influenza virus.
A major driver of the global H1N1 vaccines market is a rise in the incidence of infections across the globe. According to the World Health Organization’s 2018 factsheet estimates, 290,000 to 650,000 deaths are reported each year from all types of influenza infections (including influenza A i.e. H1N1). Worldwide, around 3 to 5 million cases of severe viral influenza infections are diagnosed each year.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60471
Rise in awareness among physicians and end-users about disease preventation and government initiatives towards reforming health are likely to boost the market in the coming years. Moreover, a strong clinical pipeline of H1N1 vaccines further contributes to the growth of the market. However, a lack of awareness and stringent regulations hinder the growth of the global H1N1 vaccines market.
The global H1N1 vaccines market can be segmented based on vaccine, route of administration, distribution channel, and geography. Based on vaccine, the market can be classified into inactivated vaccine and live attenuated vaccine. In terms of route of administration, the global H1N1 vaccines market can be categorized into parentral and nasal. Based on distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.
Get COVID-19 Analysis on H1N1 Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60471
Based on geography, the global H1N1 vaccines market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe lead the global H1N1 vaccines market in terms of revenue. This is primarily due to developed research infrastructure and increased awareness among end-users in these regions. The H1N1 vaccines market in Asia Pacific is expected to expand at a high growth rate during the forecast period, due to a rise in cases of H1N1 virus infections in the region, particularly in India and China.
Moreover, an increase in awareness among the masses about diseases and increase in government initiatives and programs to raise awareness among people about various infectious diseases in Asia Pacifc are likely to boost the market in the region. There has been a significant rise in demand for H1N1 vaccines for the prevention of swine flu. Furthermore, several companies are constructing their manufacturing and research facilities in developing regions due to availability of a large patientpool, low wages, and less stringent environment and health and safety regulations.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60471
Development of medical infrastructure, growth of economies in developing countries such as India and China, discovery of new vaccines with greater efficiency, and advancements in the field of biomedical science are expected to offer attractive opportunities to players in the H1N1 vaccines market in Asia Pacific. Frequent strategic collaborations and mergers between manufacturing companies and government associations as well as product launches are the current trends in the global H1N1 vaccines market.
Some of the major players operating in the global H1N1 vaccines market are Medimmune, GlaxoSmithKline, AstraZeneca plc, Novartis, Sanofi AG. Sinovac, Baxter, Commonwealth Serum Laboratories, Zydus Cadila, and others.
Browse more Reports by Transparency Market Research:
Clinical Trial Management System Market: Rising demand for new therapies and increasing research and developmental activities to drive the global clinical trials management system market during the forecast period. Increase in R&D investment by the pharmaceutical, life science, and clinical research industries are propelling the CTMS market.
COVID-19 Antigen Test Market: Products in the global COVID-19 antigen test market are expected to gain traction during the forecast period owing to their benefits such as shorter test to result timeline, as well as their patient friendly and easy to use nature.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453